DAVID MATTHEW T (Chief Financial Officer) received a stock award from ACTINIUM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/16/2026ACC: 0001213900-26-110340
Officer· Chief Financial Officer
Since Oct 2026
+500K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
500K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+250K
Price / share
—
Trade value
—
% of position
New position
10/14/2026
0.00→250K
Total
Net shares
+250K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/14/2026 | A · Award | +250K | — | — | New position | 0.00 | 250K |
| Total | +250K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to purchase)
Direct
Converts to
Common Stock
250K shares
Shares
+250K
Strike price
0.9750
Held after
250K
Exercisable
—
10/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase) Direct | Common Stock250K shares | 10/14/2026 | A · Award | +250K | 0.9750 | — | 250K |